These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 3148067
1. Prolinase activity in prolidase-deficient fibroblasts. Miech G, Myara I, Mangeot M, Voigtlander V, Lemonnier A. J Inherit Metab Dis; 1988; 11(3):266-9. PubMed ID: 3148067 [Abstract] [Full Text] [Related]
2. Characteristics of prolinase against various iminodipeptides in erythrocyte lysates from a normal human and a patient with prolidase deficiency. Wang W, Liu G, Yamashita K, Manabe M, Kodama H. Clin Chem Lab Med; 2004; 42(10):1102-8. PubMed ID: 15552267 [Abstract] [Full Text] [Related]
3. Amelioration of prolidase deficiency in fibroblasts using adenovirus mediated gene transfer. Ikeda K, Tohyama J, Tsujino S, Sato K, Oono T, Arata J, Endo F, Sakuragawa N. Jpn J Hum Genet; 1997 Sep; 42(3):401-8. PubMed ID: 12503186 [Abstract] [Full Text] [Related]
4. Cell density affects prolidase and prolinase activity and intracellular amino acid levels in cultured human cells. Myara I, Charpentier C, Gautier M, Lemonnier A. Clin Chim Acta; 1985 Jul 30; 150(1):1-9. PubMed ID: 4042361 [Abstract] [Full Text] [Related]
5. Substrate specificity of manganese-activated prolidase in control and prolidase-deficient cultured skin fibroblasts. Butterworth J, Priestman D. J Inherit Metab Dis; 1984 Jul 30; 7(1):32-4. PubMed ID: 6429439 [Abstract] [Full Text] [Related]
6. Different effects of sulfur amino acids on prolidase and prolinase activity in normal and prolidase-deficient human erythrocytes. Uramatsu M, Liu G, Uramatsu S, Zhang M, Wang W, Nakayama K, Manabe M, Kodama H. Clin Chim Acta; 2007 Jan 30; 375(1-2):129-35. PubMed ID: 16899234 [Abstract] [Full Text] [Related]
7. Prolidase deficiency: its dermatological manifestations and some additional biochemical studies. Arata J, Umemura S, Yamamoto Y, Hagiyama M, Nohara N. Arch Dermatol; 1979 Jan 30; 115(1):62-7. PubMed ID: 760660 [Abstract] [Full Text] [Related]
8. Characteristics of prolidase and prolinase in prolidase-deficient patients with some preliminary studies of their role in skin. Oono T, Arata J. J Dermatol; 1988 Jun 30; 15(3):212-9. PubMed ID: 3053830 [No Abstract] [Full Text] [Related]
9. Changes in prolinase and prolidase activity during CCl4 administration inducing liver cytolysis and fibrosis in rat. Myara I, Miech G, Fabre M, Mangeot M, Lemonnier A. Br J Exp Pathol; 1987 Feb 30; 68(1):7-13. PubMed ID: 3814502 [Abstract] [Full Text] [Related]
10. In-vitro responses to ascorbate and manganese in fibroblasts from a patient with prolidase deficiency and iminodipeptiduria: cell growth, prolidase activity and collagen metabolism. Myara I, Charpentier C, Wolfrom C, Gautier M, Lemonnier A, Larregue M, Chamson A, Frey J. J Inherit Metab Dis; 1983 Feb 30; 6(1):27-31. PubMed ID: 6408304 [Abstract] [Full Text] [Related]
18. Prolidase deficiency diagnosed by 1H NMR spectroscopy of urine. Moolenaar SH, Engelke UF, Abeling NG, Mandel H, Duran M, Wevers RA. J Inherit Metab Dis; 2001 Dec 29; 24(8):843-50. PubMed ID: 11916317 [Abstract] [Full Text] [Related]
19. In situ activation of human erythrocyte prolidase: potential for enzyme replacement therapy in prolidase deficiency. Hechtman P, Richter A, Corman N, Leong YM. Pediatr Res; 1988 Dec 29; 24(6):709-12. PubMed ID: 3205627 [Abstract] [Full Text] [Related]